Kofod-Hansen
Andreas Kofod-Hansen, Smorum DK
Patent application number | Description | Published |
---|---|---|
20140321682 | HEARING ASSISTANCE DEVICE WITH A LOW-POWER MODE - A portable hearing assistance device comprises an input unit, an output unit, a forward path between the input unit and the output unit, and an energy source for energizing components of the hearing assistance device. The hearing assistance device further comprises a control unit to control activation (or deactivation) of a low-power mode of operation of the hearing assistance device. When the low-power mode is activated—the draw of current from said energy source is reduced compared to a normal mode of operation of the device, the activation (or deactivation) being influenced by a combination of at least two different control input signals to the control unit, each control input signal being a signal selected from 1) signals relating to current physical environment, 2) signals relating to current acoustic environment, 3) signals relating to current wearer state, and 4) signals relating to current state or operation mode. | 10-30-2014 |
Mikael Kofod-Hansen, Kobenhavn N DK
Patent application number | Description | Published |
---|---|---|
20090036353 | Insulin Derivatives Conjugated with Structurally Well Defined Branched Polymers - Insulin conjugated with structurally well defined, bifurcated and trifurcated polymers can be use by pulmonary delivery for systemic absorption through the lungs to reduce or eliminate the need for administering other insulins by injection. | 02-05-2009 |
20090240028 | Synthesis and Application of New Structural Well Defined Branched Polymers as Conjugating Agents for Peptides - The invention provides synthesis and application of new structural well defined branched polymers as protraction agents for peptide and protein. | 09-24-2009 |
20120093840 | TARGETED DELIVERY OF FACTOR VIII PROTEINS TO PLATELETS - The invention described herein relates to novel molecules and polypeptides comprising at least one amino acid sequence having significant identity with (homology to) human Factor VIII or biologically active portion(s) thereof, related molecules (such as nucleic acids encoding such polypeptides), compositions (such as pharmaceutical formulations) comprising such polypeptides, and methods of making and using such polypeptides. | 04-19-2012 |
Mikael Kofod-Hansen, Koebenhavn N DK
Patent application number | Description | Published |
---|---|---|
20130040888 | Factor VIII Molecules With Reduced VWF Binding - The present invention relates to a recombinant Factor VIII molecule, wherein said molecule has reduced vWF binding capacity, and wherein said molecule is covalently conjugated with at least one side group. | 02-14-2013 |
20130337537 | COAGULATION FACTOR-TARGETING TO TLT-1 ON ACTIVATED PLATELETS - The current invention relates to: procoagulant proteins which may, for example, be fusion proteins or chemical conjugates; methods of producing said procoagulant proteins; polynucleotides that encode said fusion proteins and cells that expresses them. Furthermore, the current invention relates to procoagulant proteins for use as a medicament. Individuals that have a coagulopathy, such as haemophilia A and B with or without inhibitors, may be treated with the procoagulant proteins of the current invention. | 12-19-2013 |
Mikael Kofod-Hansen, Koebenhavn DK
Patent application number | Description | Published |
---|---|---|
20130071383 | SELECTIVE MODIFICATION OF PROTEINS - A method of selectively introducing a substituent into a protein proximal to a binding site on the protein for a homing peptide, comprising: (a) contacting the protein with a compound comprising a homing peptide having the ability to bind to the binding site of the protein; and (b) allowing a moiety on the protein proximal to the binding site to react with the compound comprising the homing peptide, thereby to transfer the substituent G onto the protein. | 03-21-2013 |